Two-Dose Vaccines and the Acceleration of Post-Exposure Response
In an anthrax emergency, speed determines survival. The faster protective immunity can be established after exposure, the better the outcome—and vaccine dosing schedules are a critical constraint. For years, the post-exposure regimen required three doses over four weeks. The FDA's July 2023 approval of CYFENDUS, a two-dose adjuvanted vaccine, compressed that timeline, and the shift is...
0 Σχόλια 0 Μοιράστηκε 2 Views 0 Προεπισκόπηση